Fri, Aug 29, 2014, 10:57 AM EDT - U.S. Markets close in 5 hrs 3 mins

Recent

% | $
Quotes you view appear here for quick access.

Genomic Health Inc. Message Board

mdwhittier 61 posts  |  Last Activity: Aug 26, 2014 8:48 PM Member since: Sep 17, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • mdwhittier mdwhittier Aug 26, 2014 8:48 PM Flag

    Really? And why should any board member here truly care about your position? Honestly, I can't think of a reason why anyone here would, or should care. How about considering not posting when you buy back in. Again, we don't care. Oh, and you are on permanent IGNORE! For being boring.

    Sentiment: Strong Buy

  • mdwhittier mdwhittier Aug 25, 2014 6:04 PM Flag

    A lot. You're such a pathetic tool.

    Sentiment: Strong Buy

  • Reply to

    After Hours Buy

    by mdwhittier Aug 25, 2014 4:34 PM
    mdwhittier mdwhittier Aug 25, 2014 6:02 PM Flag

    That's an interesting thing to note. Wonder if they were stock options being exercised? Anybody else have ideas?

    Sentiment: Strong Buy

  • mdwhittier by mdwhittier Aug 25, 2014 4:34 PM Flag

    Of 126k shares @ $4.21 An institutional buy, no doubt. Looks like accumulation to me.

    Sentiment: Strong Buy

  • mdwhittier mdwhittier Aug 25, 2014 4:30 PM Flag

    Sure. He was simply offering his opinion about the share price, based on the likelihood of the success of Etep. and follow-on exon candidates. He implies that SRPT is on the cusp of greatness with their PMO platform, and since they own a large piece of the PMO intellectual property, they stand to benefit from future applications of that technology. Remember, his mentioned timeline is 5-10 years. Could SRPT be a 10 bagger from here in 5 years? I have no doubt whatsoever. And in the following 5 years even more.

    C.G. is a sharp & determined CEO who has taken a lot of knocks b/c folks here think he's poorly managed the Etep. trial, and failed in interactions with FDA. The reality is that FDA has taken a long time to get up to speed on what the science/technology is all about, and how future clinical designs should be designed. We're finally on the right track, but it's not his fault that an agency as big as FDA is a slow and lumbering machine, with staff members who have a lot to grapple with to understand the science. It doesn't help that dystrophin isn't easy to measure and quantify. This too is about to change. In 6 months, things will look a lot different. Patience is a virtue. GLTA

    Sentiment: Strong Buy

  • Reply to

    EXPECT BREAKING NEWS SOON

    by usagary1 Aug 20, 2014 3:59 PM
    mdwhittier mdwhittier Aug 20, 2014 11:48 PM Flag

    C'mon Gary......you can be so much better than this. You sound like a mindless pumper. Time to swear off the pointless posts.

    Sentiment: Strong Buy

  • Reply to

    SRPT

    by carpet310 Aug 19, 2014 10:35 AM
    mdwhittier mdwhittier Aug 19, 2014 11:25 AM Flag

    The question is: Who is going to pay for any further drug development and manufacturing? If the DOD is going to pony up funds, that process would take many weeks to get green lighted and then a contract would have to be drafted.

    And, to administer drugs that have not completed scientific, evidenced-based analysis on humans, is a slippery slope. If the drug were administered to sick patients at early/mid/late stages of infection, who would keep track of which persons apparently responded to drug, so there would be some attempt to determine some type of efficacy. Sick people given drugs, who then later died, would be thought by poorly educated rural populations to have been poisoned. The entire process of giving unproven drugs to hundreds of sick people is fraught with problems. If the current ebola outbreak reached a pandemic stage, there would be more incentive to take these risks. We're not there yet.

    The best we can hope for right now is that SRPT is in talks with the DOD to reboot clinical trials that would highlight SRPT's drug technology, bring in additional revenue, and further the cause for a treatment for ebola that would save lives.

    Sentiment: Strong Buy

  • Reply to

    For the "No $$ in Ebola" Camp

    by mdwhittier Aug 8, 2014 1:13 PM
    mdwhittier mdwhittier Aug 8, 2014 3:23 PM Flag

    Perfect response to pasteur420. Blowing up a plane is unquestionably devastating for all affected parties. Someone purposely spreading ebola virus around while in a sickened state, in an urban area, would increase the fear factor in a massive way. It's not just killing people that is on the agenda of terrorist groups, it's creating fear and panic. The concern here is legitimate.

    Sentiment: Strong Buy

  • This discussion has already happened within govt. anti-terrorist think tanks: An extremist Muslim, who would consider blowing themselves up as a martyr, is now willing to become infected with ebola, and then transport themselves to an EU country, or even the U.S. Don't think this hasn't crossed the minds of terrorists factions already. While extremist terrorist groups typically prefer to make a large footprint for media consumption with a big kill factor (blowing up airplanes), inciting fear and wrecking havoc in capitalist countries is always on their agenda.

    There's no question that with the potentially long incubation period for ebola, this virus can easily be transmitted intercontinentally by an already infected but asymptomatic individual. The level of concern about this reality is high, for a very good reason. Ramping up drug production of experimental, but high probability of success drugs just makes sense. I have no doubt C.G. is currently in talks with govt. officials about doing just that.

    Can SRPT continue along the path towards AA with Etep. and ramp up production of drug for Ebola, without losing focus on DMD? Of course they can. The DMD work will get done, and the ramp up for AVI-7537 won't slow that down a bit. I believe SRPT has an AVII satellite lab in Corvallis, Oregon, capable of producing that drug, but I need to confirm that.

    Sentiment: Strong Buy

  • Reply to

    Don't Worry, SRPT Won't Be Left Out

    by hogan516 Aug 8, 2014 7:37 AM
    mdwhittier mdwhittier Aug 8, 2014 12:49 PM Flag

    Okay, consider this. What about an extremist Muslim, who would consider blowing themselves up as a martyr, is now willing to become infected with ebola, and then transport themselves to the EU. Don't think this hasn't crossed the minds of terrorists already.

  • mdwhittier mdwhittier Aug 7, 2014 3:27 PM Flag

    The article by AF, which you refer to as: "another crushing piece" - wasn't all that crushing, just an honest opinion (which I don't necessarily agree with. And, about today's price drop...get a clue. It had nothing to do with his opinion post.

    Sentiment: Strong Buy

  • mdwhittier mdwhittier Aug 7, 2014 3:20 PM Flag

    Exactly! And thanks for the comment, bionerd.
    Btw, what's your opinion of the disclaimer re: patent issues. I know this isn't your area of expertise, but wondering what your thoughts are. TIA

    Sentiment: Strong Buy

  • Reply to

    Mdwhit

    by starfe11 Aug 7, 2014 1:18 PM
    mdwhittier mdwhittier Aug 7, 2014 1:49 PM Flag

    Okay, I get it.....you're angry, you like to throw a tantrum......and just keep it going on. It's boring, childish...and I'm just going to IGNORE your rants.

    Sentiment: Strong Buy

  • Reply to

    Mdwhit

    by starfe11 Aug 7, 2014 1:18 PM
    mdwhittier mdwhittier Aug 7, 2014 1:37 PM Flag

    You'll be counting a long time, starfe. Company resources dictate drug development, so "turned flu into nothing" is bs red herring, and "cry for ebola even looks desperate" distorts the fact that this was a govt. contract that dried up, and the company was contacted by media, not the other way around. Your spin of facts is pathetic, and your "get rid of CG" drum pounding is wishful thinking.

    Sentiment: Strong Buy

  • Reply to

    His dedication to the company

    by starfe11 Aug 7, 2014 1:04 PM
    mdwhittier mdwhittier Aug 7, 2014 1:12 PM Flag

    3 years ago the company was a $2 stock and nearly broke, with just enough $$ to produce sufficient drug for a small Ph2 trial. You're massively myopic starfe; seems you feel entitled to a 10bagger in under 3 years. Get over it.

    Sentiment: Strong Buy

  • mdwhittier by mdwhittier Aug 7, 2014 1:02 PM Flag

    This is what the market is focusing on today; hence the downdraft due to the overhang of unknowns. It seems to me that this language is standard disclaimer legalese that can be found in every biotech company 's disclaimer section; just plug in the variables for their situation. The bears will take any negative spin, amplify it and push it hard for their short positions. Those disgruntled longs calling for C.G. to go give him no credit for what's happened in the past two years. His dedication to the company, and passion for helping the DMD community by moving Etep forward, is unsurpassed in the biotech universe. Insider selling? I don't see anybody lining their pockets here.

    Sentiment: Strong Buy

  • Reply to

    ITMN: scary price movement

    by chaulagaichet Jul 24, 2014 12:29 PM
    mdwhittier mdwhittier Aug 6, 2014 5:08 PM Flag

    You are clearly an idiot; IGNORE WORTHY

    Sentiment: Strong Buy

  • Reply to

    Question for the Long Termers

    by gizmo_puppy95 Aug 5, 2014 7:15 PM
    mdwhittier mdwhittier Aug 5, 2014 7:47 PM Flag

    Gizmo, really? You are soooo late to this conversation, it's almost sad. How about going to the SRPT's website and do a little DD on your own, before asking board members to spoon feed you all the developments in the past year.

    Sentiment: Strong Buy

  • Reply to

    SRPT going to SINGLE DIGITS.

    by ipsosfund1 Aug 3, 2014 3:35 PM
    mdwhittier mdwhittier Aug 3, 2014 5:17 PM Flag

    The "pigs" who will get slaughtered will be the shorts, who are the real pigs here, and have been repeating the "low N clinical trial" mantra for too long. The Twitterverse is ablaze with whatever you pay attention to. It's not the collective conscious for predicting share price. It's probably balanced between bulls/bears right now. We have an exon-skipping drug that works in mice, dogs and humans, with clear efficacy and no evidence of adverse events. If you're not margined, you have nothing much to worry about, IMHO.

    If you're new to the board, Google this: DMD: Exon-Skipping Timeline A good graphic on the progress.

    Good luck with waiting until 8 bucks a share. Won't. Ever. Happen.

    Sentiment: Strong Buy

  • Reply to

    Trading Halt

    by sheepputs Aug 3, 2014 11:47 AM
    mdwhittier mdwhittier Aug 3, 2014 11:55 AM Flag

    Okay, sheepputs....how about taking your educational posts to another venue. It's tiresome already. You have no idea how many posters like you end up on ignore. Your audience is much smaller than you imagine.

GHDX
29.45+0.33(+1.13%)10:44 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.